About Me
As a Ph.D. scholar specializing in drug design, my research focuses on the development of novel therapeutic compounds through the application of advanced computational and experimental methods. I explore the structure-activity relationships (SAR) of biologically active molecules, utilizing techniques such as molecular docking, molecular dynamics simulations, and quantitative structure-activity relationship (QSAR) modeling to predict and optimize drug efficacy and safety profiles. My work integrates pharmacophore modeling, target identification, and ligand-based design approaches to discover potential drug candidates for a range of diseases, including cancer, neurodegenerative disorders, and infectious diseases. I am also deeply involved in the study of ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties to ensure that lead compounds meet the necessary pharmacokinetic and pharmacodynamic criteria for further development.